Summary
https://kalkinemedia.com/au/sponsor...ettle-with-a-slew-of-developments-across-q321
- SUDA Pharmaceuticals Ltd (ASX:SUD) released its Appendix 4C for the consolidated group for the third quarter of FY 2021 (Q321).
- The firm continued to make major strides across Q321 and SUDA’s cash balance was A$4.28 million by the end of the period.
- The team has uncovered new technologies that are currently under review.
Ann: Quarterly Appendix 4C and Activities Report, page-26
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
-0.005(3.45%) |
Mkt cap ! $147.2M | |||
| Open | High | Low | Value | Volume |
| 14.5¢ | 15.0¢ | 14.0¢ | $123.9K | 855.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 968061 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 22086 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| ALA (ASX) Chart |